Carcinogenesis, Vol. 22, No. 7, 1015-1018,
July 2001
© 2001 Oxford University Press
ACCELERATED PAPER |
Myeloperoxidase – 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients
German Cancer Research Center (DKFZ), Division of Toxicology and Cancer Risk Factors, PO Box 101949, D-69009 Heidelberg, Germany,
1 Ernst Moritz Arndt, University Institute of Pharmacology, Medical Faculty, Friedrich-Loeffler-Strasse 23d, D-17487 Greifswald, Germany,
2 Straat van Gibraltar 32, NL-1183 GW Amstelveen, The Netherlands,
3 University Hospital Maastricht (AzM), Department of Dermatology, PO Box 5800, NL-6202 AZ Maastricht, The Netherlands and
4 Maastricht University, Department of Health Risk Analysis and Toxicology, PO Box 616, NL-6200 MD Maastricht, The Netherlands
The skin of atopic dermatitis patients provides an excellent model to study the role of inflammation in benzo[a]pyrene (BaP) activation, since these individuals are often topically treated with ointments containing high concentrations of BaP. In this study we have determined, by HPLC with fluorescence detection, the BaP diol epoxide (BPDE)–DNA adduct levels in human skin after topical treatment with coal tar and their modulation by the –463G
A myeloperoxidase (MPO) polymorphism, which reduces MPO mRNA expression. BPDE–DNA adduct levels were 2.2 and 14.2 adducts/108 nt for MPO–463AA/AG and –463GG, respectively. The predominant BaP tetrol observed was tetrol I-1, which is derived after hydrolysis of the anti-BPDE–DNA adduct. The tetrol I-1/II-2 ratio, corresponding to the anti/syn ratio, was 6.7. The 32P-post-labeling assay was also performed and thin layer chromatograms showed a major spot with a chromatographic location corresponding to BPDE–DNA. The mean values of the BPDE–DNA adduct spots were 3.8 ± 2.4 per 108 nt for MPO–463AA/AG (n = 3) and 18.4 ± 11.0 per 108 nt for MPO–463GG (n = 7), respectively (P = 0.03). One individual with the homozygous mutant genotype (–463AA) even had a 13-fold lower adduct level (1.4 per 108 nt) as compared to MPO–463GG subjects. In conclusion, these data show for the first time: (i) the in vivo formation of BPDE–DNA adducts in human skin treated with coal tar; (ii) that the MPO–463AA/AG genotype reduced BPDE–DNA adduct levels in human skin.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Zhou, Y. Jiang, A. Tan, A. R. Greenlee, Y. Shen, L. Liu, and Q. Yang Silencing of N-Ras Gene Expression Using shRNA Decreases Transformation Efficiency and Tumor Growth in Transformed Cells Induced by Anti-BPDE Toxicol. Sci., October 1, 2008; 105(2): 286 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Alexandrov, M. Rojas, and C. Rolando DNA Damage by Benzo(a)pyrene in Human Cells Is Increased by Cigarette Smoke and Decreased by a Filter Containing Rosemary Extract, Which Lowers Free Radicals Cancer Res., December 15, 2006; 66(24): 11938 - 11945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Knaapen, N. Gungor, R. P. F. Schins, P. J. A. Borm, and F. J. Van Schooten Neutrophils and respiratory tract DNA damage and mutagenesis: a review Mutagenesis, July 1, 2006; 21(4): 225 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Van Schooten, A. W. Boots, A. M. Knaapen, R. W. L. Godschalk, L. M. Maas, P. J. A. Borm, M. Drent, and J. A. Jacobs Myeloperoxidase (MPO) -463G->A Reduces MPO Activity and DNA Adduct Levels in Bronchoalveolar Lavages of Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 828 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Nair, H. Bartsch, and J. Nair Prevention of degenerative diseases; clues from studies investigating oxidative stress, Brussels, 13 November 2002 Mutagenesis, September 1, 2003; 18(5): 477 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dally, H. Bartsch, and A. Risch Correspondence re: Feyler et al., Point: Myeloperoxidase -463G -> A Polymorphism and Lung Cancer Risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu et al., Counterpoint: The Myeloperoxidase -463G -> A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians. 11: 1555-1559, 2002 Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 683 - 683. [Full Text] [PDF]
|
|